Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban for prevention of early progression in acute non-large vessel occlusion ischemic stroke
ChiCTR2200061110Phase 4Recruiting
- Sponsor
- The Sixth Affiliated Hospital of Jinan University
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban in ischemic stroke (2 arms), sponsored by The Sixth Affiliated Hospital of Jinan University. Primary endpoint: Incidence of early neurological deterioration within 7 days. Started Jun 2022; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2200061110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061110.